Table 2.

Clinical variables-wise categorization of the LUAD cohort analyzed via UALCAN

Sr. No	Clinical variable	Samples count per variable	Total samples count	Sample count having missing details	Final sample count subjected to analysis
1	Cancer stage
	Stage 1	n, 277		n, 0	n, 515
	Stage 2	n, 125
	Stage 3	n, 85
	Stage 4	n, 28
2	Age
	years = 21-40	n, 12	n, 515	n, 232	n, 283
	years = 41-60	n, 90
	years = 61-80	n, 149
	years = 81-100	n, 32
3	Geographical distribution
	Caucasian	n, 387		n, 73	n, 442
	African-American	n, 51
	Asian	n, 8
4	TP53 mutation status
	TP53-Mutatnt	n, 233		n, 3	n, 512
	TP53-NonMutant	n, 279

LUAD = Lung adenocarcinoma, UALCAN = University of ALabama at Birmingham CANcer.